Skip to content

The Clinical Efficacy Evaluation of Acupuncture with Raising Clearing and Lowering Turbidity for Gastrointestinal Dysfunction due to Septicemia

The Clinical Efficacy Evaluation of Acupuncture with Raising Clearing and Lowering Turbidity for Gastrointestinal Dysfunction due to Septicemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000104
Enrollment
Unknown
Registered
2025-01-14
Start date
2023-06-28
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

control group:sham acupuncture
experimental group:acupuncture

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with gastrointestinal dysfunction due to sepsis. 2. Age = 18 years old both male and female are acceptable. 3. The patient himself/herself or the guardian signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who need synchronous combined with other surgeries. 2. Patients who have received acupuncture treatment within one month. 3. Patients with a pacemaker. 4. Patients with a history of syncope or epilepsy; patients using immunomodulators or with immunodeficiency; patients with malignant tumor diseases; patients with a history of gastrointestinal resection or in the recovery period of gastrointestinal or abdominal cavity surgery. 5. Patients with damaged ulcerated or infected skin or subcutaneous tissue at the acupoint area. 6. Patients who have participated in other clinical studies within the recent three months.

Design outcomes

Primary

MeasureTime frame
Acute Gastrointestinal Injury Ultrasound Score(AGIUS Score);

Secondary

MeasureTime frame
Gastric Emptying Delay Monitoring;Lymphocyte Count;Sequential Organ Failure Assessment Score;Tumor Necrosis Factor-a(TNF-a);Systemic Immune Inflammatory Index(SII);White Blood Cell Count(WBC);Interleukin-17A(IL-17A);28-day Mortality Rate;Procalcitonin(PCT);Interleukin-6(IL-6);Neutrophil Count(NEUT);Interleukin-10(IL-10);Incidence of Feeding Intolerance;The Time to Reach the Target Calorie;Daily Calorie Intake;

Countries

China

Contacts

Public ContactXiaokun Yang

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

yxk.666@163.com13820674865

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026